WallStSmart

Elevance Health Inc (ELV)vsNewmont Goldcorp Corp (NEM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Elevance Health Inc generates 703% more annual revenue ($200.42B vs $24.97B). NEM leads profitability with a 33.9% profit margin vs 2.6%. ELV appears more attractively valued with a PEG of 1.47. NEM earns a higher WallStSmart Score of 78/100 (B+).

ELV

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 5.5Value: 6.7Quality: 6.0
Piotroski: 4/9Altman Z: 2.66

NEM

Strong Buy

78

out of 100

Grade: B+

Growth: 10.0Profit: 9.0Value: 4.0Quality: 8.5
Piotroski: 7/9Altman Z: 2.11
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ELVUndervalued (+4.5%)

Margin of Safety

+4.5%

Fair Value

$416.35

Current Price

$415.53

$0.82 discount

UndervaluedFair: $416.35Overvalued
NEMSignificantly Overvalued (-79.6%)

Margin of Safety

-79.6%

Fair Value

$60.39

Current Price

$108.35

$47.96 premium

UndervaluedFair: $60.39Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ELV4 strengths · Avg: 8.3/10
Market CapQuality
$87.28B9/10

Large-cap with strong market position

P/E RatioValuation
17.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$4.10B8/10

Generating 4.1B in free cash flow

NEM6 strengths · Avg: 9.7/10
Profit MarginProfitability
33.9%10/10

Keeps 34 of every $100 in revenue as profit

Operating MarginProfitability
61.4%10/10

Strong operational efficiency at 61.4%

Revenue GrowthGrowth
45.8%10/10

Revenue surging 45.8% year-over-year

EPS GrowthGrowth
78.6%10/10

Earnings expanding 78.6% YoY

Market CapQuality
$115.77B9/10

Large-cap with strong market position

Return on EquityProfitability
24.2%9/10

Every $100 of equity generates 24 in profit

Areas to Watch

ELV3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Profit MarginProfitability
2.6%3/10

2.6% margin — thin

EPS GrowthGrowth
-16.8%2/10

Earnings declined 16.8%

NEM1 concerns · Avg: 2.0/10
PEG RatioValuation
2.782/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : ELV

The strongest argument for ELV centers on Market Cap, P/E Ratio, Price/Book. PEG of 1.47 suggests the stock is reasonably priced for its growth.

Bull Case : NEM

The strongest argument for NEM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 33.9% and operating margin at 61.4%. Revenue growth of 45.8% demonstrates continued momentum.

Bear Case : ELV

The primary concerns for ELV are Revenue Growth, Profit Margin, EPS Growth. Thin 2.6% margins leave little buffer for downturns.

Bear Case : NEM

The primary concerns for NEM are PEG Ratio.

Key Dynamics to Monitor

ELV profiles as a value stock while NEM is a growth play — different risk/reward profiles.

ELV carries more volatility with a beta of 0.68 — expect wider price swings.

NEM is growing revenue faster at 45.8% — sustainability is the question.

ELV generates stronger free cash flow (4.1B), providing more financial flexibility.

Bottom Line

NEM scores higher overall (78/100 vs 56/100), backed by strong 33.9% margins and 45.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Elevance Health Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.

Newmont Goldcorp Corp

BASIC MATERIALS · GOLD · USA

Newmont Corporation, based in Greenwood Village, Colorado, United States, is one of the largest gold mining companies in the world.

Visit Website →

Want to dig deeper into these stocks?